<DOC>
	<DOC>NCT00198237</DOC>
	<brief_summary>The primary objective of this study is to determine the efficacy &amp; toxicity of combined docetaxel &amp; capecitabine as primary chemo for subjects w/ stage II-III breast cancer.</brief_summary>
	<brief_title>Genomic &amp; Proteomic Analysis of Docetaxel &amp; Capecitabine as Primary Chemo for Stage II-III Breast Cancer</brief_title>
	<detailed_description>The primary objective of this study is to determine the efficacy &amp; toxicity of combined docetaxel &amp; capecitabine as primary chemotherapy for subjects with stage II-III breast cancer.Subjects will be randomized into one of two groups: Docetaxel followed by four cycles of docetaxel &amp; capecitabine vs. capecitabine followed by four cycles of docetaxel and capecitabine.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Histologically confirmed adenocarcinoma of the breast w/ Stage IIIII disease w/ a primary tumor &gt;/=2cm or clinically palpable axillary lymph nodes. Pretreatment core or incisional bx w/ adequate tissue for histology &amp; genomic/proteomic analysis. Primary tumor must be bidimensionally measurable by physical exam or dx breast imaging. Measurements must be obtained w/in 3 wks prior to study entry. Adequate organ fxn:AGC&gt;1500; Hb&gt;/=9.0;plts&gt;/=100K; Crt&lt;/=2.0;Cacl Crt Clr&gt;/=50; total bili&lt;/=ULN; LFTs&lt;2.0 ULN ECOG performance status 01 Neg. pregnancy test Pts may not have had definitive primary surgery. Metastatic breast cancer Any prior chemo or hormonal therapy for breast cancer Prior history of malignancy w/in the previous 5 yrs. No active unresolved infection No major surgery w/in 2wks of start of study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Stage II Breast Cancer</keyword>
	<keyword>Stage III Breast Cancer</keyword>
</DOC>